- Home
- FNWB vs IOBT Comparison
FNWB vs IOBT Comparison
Compare FNWB & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FNWB | IOBT |
|---|---|---|
| Founded | 1923 | 2014 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 26.6M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FNWB | IOBT |
|---|---|---|
| Price | $8.88 | $0.17 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $13.50 | $2.25 |
| AVG Volume (30 Days) | 26.7K | ★ 1.0M |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.79% | N/A |
| EPS Growth | ★ 36.00 | 26.77 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $176,000.00 | N/A |
| Revenue This Year | $19.24 | N/A |
| Revenue Next Year | $8.90 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.05 | $0.19 |
| 52 Week High | $10.98 | $2.79 |
Technical Indicators
Market Signals| Indicator | FNWB | IOBT |
|---|---|---|
| Relative Strength Index (RSI) | 25.36 | 23.76 |
| Support Level | $7.56 | N/A |
| Resistance Level | $9.00 | $0.40 |
| Average True Range (ATR) | 0.33 | 0.03 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 4.79 | 14.97 |
Price Performance
Historical ComparisonAbout FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.